In mid-March 2007, Chris Kreider sat in his office and thought about how best to finance the growth of their company. Over the past five years, the founder and CEO of D2Hawkeye, Waltham, Massachusetts-based medical analysts, Crider company grew from six people running into the leading developer and supplier of health analysts in the United States had three term sheets in hand - two from strategic investors and a from venture capital firms. Each proposal has its advantages and disadvantages, and Kreider need to decide which offer to accept. "Hide
by Robert F. Higgins, Brent Kazan, Sophie Lamontagne Source: Harvard Business School 25 pages. Publication Date: November 11, 2007. Prod. #: 808006-PDF-ENG